VisiDisc® is a dehydrated amniotic membrane allograft disc, designed for use in ophthalmology applications.
VisiDisc® is available in two thicknesses, for optimal handling in a variety of applications.
VisiDisc®45 is a thinner graft, derived from amnion membrane, providing a versatile graft for a range of applications. It has a nominal thickness of 45 microns.
VisiDisc®200 is a thicker, chorion-based graft, providing alternative handling characteristics and visibility. It has a nominal thickness of 200 microns.
|IDEAL HANDLING DRY OR WET
VisiDisc® is scientifically dehydrated for optimal structural integrity and handling. This allows the graft to be applied dry, or pre-moistened for easy application into tight areas. Read more about the unique HydraTek® process here.
VisiDisc® adheres naturally to the patient’s tissues. If necessary, light fixation or a bandage covering may be utilized to keep the graft in place.
VisiDisc® can be applied in either direction, with no orientation issues.
Amniotic membranes are considered ‘immune privileged’, meaning they induce little or no immune response in the patient, which can lead to graft failure or fibrosis. No blood typing or donor matching is required.
VisiDisc® is provided sterile in a dual peel-pouch, and may be introduced to the sterile field.
VisiDisc® is stored at ambient temperature (50-86°F/10-30°C) until ready for use. Product has a 5 year shelf life.
NOTE Skye Biologics, Inc. make no claims concerning the biological properties of any product or potential outcomes as a result of the use of any product. Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. The results reported may not necessarily occur in all individuals. Skye Biologics is providing this site and its contents on an “as is” basis and makes no representations or warranties of any kind with respect to this site or its contents. All tissues have been collected, processed, stored and distributed in compliance with FDA regulations governing HCT/Ps.